Editorial
doi: 10.1046/j.1537-2995.1996.36796323056.x.
Allogeneic marrow reconstitution using peripheral blood stem cells: the dawn of a new era
- PMID: 8701452
- DOI: 10.1046/j.1537-2995.1996.36796323056.x
Item in Clipboard
Editorial
Allogeneic marrow reconstitution using peripheral blood stem cells: the dawn of a new era
Transfusion.
1996 Jul.
No abstract available
Comment in
-
Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.Transfusion. 1996 Jul;36(7):601-10. doi: 10.1046/j.1537-2995.1996.36796323059.x. Transfusion. 1996. PMID: 8701455
Comment on
-
Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures.Transfusion. 1996 Jul;36(7):590-5. doi: 10.1046/j.1537-2995.1996.36796323057.x. Transfusion. 1996. PMID: 8701453
-
Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors.Transfusion. 1996 Jul;36(7):596-600. doi: 10.1046/j.1537-2995.1996.36796323058.x. Transfusion. 1996. PMID: 8701454
-
Peripheral blood progenitor cells for marrow reconstitution: mobilization and collection strategies.Transfusion. 1996 Jul;36(7):611-24. doi: 10.1046/j.1537-2995.1996.36796323060.x. Transfusion. 1996. PMID: 8701456 Review.
Similar articles
-
Allogeneic peripheral blood progenitor cells: current status and future directions.J Hematother. 1996 Aug;5(4):331-7. doi: 10.1089/scd.1.1996.5.331. J Hematother. 1996. PMID: 8877708 Review.
-
Thrombocytopenia in allogeneic peripheral blood stem cell collections.Transfusion. 1996 Jul;36(7):668-9. doi: 10.1046/j.1537-2995.1996.36796323066.x. Transfusion. 1996. PMID: 8701463 No abstract available.
-
Source of stem cell rescue: bone marrow versus peripheral blood progenitors.J Hematother. 1993 Winter;2(4):521-3. doi: 10.1089/scd.1.1993.2.521. J Hematother. 1993. PMID: 7522110 Review.
-
Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts.Bone Marrow Transplant. 1999 Feb;23(3):243-9. doi: 10.1038/sj.bmt.1701579. Bone Marrow Transplant. 1999. PMID: 10084255
-
The biology and clinical uses of blood stem cells.Blood. 1997 Apr 1;89(7):2233-58. Blood. 1997. PMID: 9116266 Review. No abstract available.
Cited by
-
Long-term outcomes of peripheral blood stem cell unrelated donors mobilized with filgrastim.Blood Adv. 2024 Aug 13;8(15):4196-4206. doi: 10.1182/bloodadvances.2024012646. Blood Adv. 2024. PMID: 38687368 Free PMC article.
-
Graft Source Choice.Adv Exp Med Biol. 2025;1475:57-75. doi: 10.1007/978-3-031-84988-6_4. Adv Exp Med Biol. 2025. PMID: 40488824 Review.
-
Bone Marrow as a Hematopoietic Stem Cell Source for Gene Therapy in Sickle Cell Disease: Evidence from Rhesus and SCD Patients.Hum Gene Ther Clin Dev. 2017 Sep;28(3):136-144. doi: 10.1089/humc.2017.029. Epub 2017 Apr 17. Hum Gene Ther Clin Dev. 2017. PMID: 28447889 Free PMC article.
-
Bone Marrow Harvest: A White Paper of Best Practices by the NMDP Marrow Alliance.Transplant Cell Ther. 2024 Jul;30(7):663-680. doi: 10.1016/j.jtct.2024.04.010. Epub 2024 Apr 18. Transplant Cell Ther. 2024. PMID: 38642840 Free PMC article.
-
Manual accidents, biological risk control, and quality indicators at a children's hospital in north-east Italy.Risk Manag Healthc Policy. 2015 Apr 13;8:37-43. doi: 10.2147/RMHP.S77490. eCollection 2015. Risk Manag Healthc Policy. 2015. PMID: 25926762 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
